期刊文献+

人附睾蛋白4单克隆抗体的制备和鉴定

Preparation and identification of monoclonal antibodies against human epididymisprotein 4, HE4
原文传递
导出
摘要 目的建立人附睾蛋白4(HE4)杂交瘤细胞株,并对其分泌的HE4单克隆抗体进行鉴定和初步应用,为HE4的功能研究和人源化抗体的制备奠定基础。方法使用pcDNA3.0-HE4重组质粒免疫BALB/C小鼠,采用PEG融合技术建立杂交瘤细胞株,制备单克隆抗体。通过免疫荧光法、有限稀释法及金标斑点法测定单克隆抗体的交叉反应性及免疫球蛋白的类型和亚类。结果获得2株可稳定分泌HE4单克隆抗体的杂交瘤细胞株,分别命名为1C5和1C8,均为IgMκ类。2株单抗能够与表达HE4蛋白的卵巢癌细胞发生反应,而不与Sp2/0细胞、CHO细胞等发生交叉反应。杂交瘤细胞株1C5培养上清效价为1∶160,腹水效价为1∶1 280,而杂交瘤细胞株1C8培养上清效价为1∶128,腹水效价为1∶1 024。结论成功地制备出两株抗HE4单克隆抗体,均具有良好的特异性,为进一步建立免疫分析方法,进行HE4相关研究奠定了良好的基础。 Objective To construct and identify the hybridoma cell lines for human epididymisprotein 4(HE4), and lay a foundation of using HE4 monoclonal anitboies for HE4 functional study and humanized antibody preparation for early diagnosis and treatment of human ovarian cancer. Methods BALB / C mice were immunized with recombinant plasmid pcDNA3.0-HE4. Hybridoma cell lines were obtained using PEG fusion technology to prepare monoclonal antibodies. The immunoglobulin class, subclass, and cross-reaction of the mAbs were analyzed by immunofluorescence, limiting dilution and dot immunogold methods. Results Two hybridoma cell lines were obtained, which can stably secrete HE4 mAbs namely 1C5 and 1C8, and both were IgMκ class. The two mAbs reacted to the X cells that can express HE4, but did not cross-react to Sp2 / 0 cells and CHO cells. The culture supernatant titer of hybridoma cell line 1C5 was 1 ∶160, and peritoneal fluid was 1∶1 280. The culture supernatant titer of hybridoma cell line 1C8 was 1∶128 and peritoneal fluid was 1∶1 024.Conclusion Two mAbs against HE4 with high specificity were successfully established, which lay a good basis for further studies of HE4 and human ovarian cancer.
出处 《热带医学杂志》 CAS 2014年第8期1030-1032,1040,F0002,共5页 Journal of Tropical Medicine
基金 广东省人口和计划生育委员会科研项目(20133093)
关键词 卵巢癌 人附睾蛋白4 DNA免疫 单克隆抗体 ovarian cancer HE4 DNA immunity monoclonal antibody
  • 相关文献

参考文献8

  • 1Llauradó M,Majem B,Altadill T,et al. MicroRNAs as prognostic marker in ovarian cancer[J]. Mol Cell Endocrinol,2014,390(1-2):73-84.
  • 2Bast RC Jr,Brewer M,Zou C,et al. Prevention and early detection of ovarian cancer:mission impossible[J]?Recent Results Cancer Res,2007,174:91-100.
  • 3Picard M,Matulonis UA,Castells M. Chemotherapy hypersensitivity reactions in ovarian cancer[J]. J Natl Compr Canc Netw,2014,12(3):389-402.
  • 4Simmons AR,Baggerly K,Bast RC Jr. The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas[J]. Oncology,2013,27(6):548-556.
  • 5曹开源,杨羚,徐霖,袁广卿,张甜,丘少鹏,沈关心.抗前列腺特异性膜抗原膜外区多肽单克隆抗体的研制及初步应用[J].热带医学杂志,2008,8(3):232-234. 被引量:1
  • 6Wang B,Ugen KE,Srikantan V,et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1[J]. Proc Natl Acad Sci USA,1993,90(9):4156-4160.
  • 7Seo N,Egawa K. Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens[J]. Cancer Immunol Immunother,1994,38(4):277-280.
  • 8马卉. 基因免疫制备新城疫病毒磷蛋白的单克隆抗体[D]. 扬州:扬州大学,2005.

二级参考文献5

  • 1徐志凯.实用单克隆抗体技术[M].西安:陕西科学技术出版社,1991.
  • 2Rittenhouse HG,Finlay JA,Mikolajczyk SD,et al. Human Kallikrein 2 (hk2) and prostate specific antigen (PSA) : two closely related, but distinct, kallikreins in the prostate [J ]. Crit Rev Clin lab Sci, 1998,35(4) :275-368.
  • 3方笑雷,范医东,刘照旭,等.前列腺疾病的诊断与治疗[M].北京:科学出版社,1993:348-429.
  • 4Moffatt S, Cristiano RJ. PEGylated J591 mAb loaded in PLGAPEG-PLGA tri-block copolymer for targeted delivery: In vitro evaluation in human prostate cancer cells [J]. Int J Pharm, 2006,5 : 1-4.
  • 5Rossi MC, Zetter B. Selective stimulation of prostatic carcinoma cell proliferation by transferrin [J]. Proc Natl Acad Sci USA, 1992,89 : 6197-6201.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部